A dose of higher costs. With drug manufacturers being hit with new fees from distributors, providers and GPOs face new pricing pressures.
There's change afoot among drug distributors, who are hitting manufacturers with new fees. Those pricing pressures are expected to be felt elsewhere in the industry. "I think the impact will eventually ... be felt in some way by providers in increased cost or lack of product," says Larry Dooley, left, of Novation.
Cinda
C
Becker
D032982:Contracts; D016527:Drug Costs / Q000639:trends*; D004345:Drug Industry / Q000191:economics*; D005249:Fees and Charges; D017754:Group Purchasing / Q000191:economics* / Q000639:trends; D017721:Hospital Costs / Q000639:trends*; D014481:United States